THE THERAPEUTIC VALUE OF 1,6-BIS-(BETA-MESYLOXYETHYLAMINO)-1,6-DIDESOXY-D-MANNITE DICHLORHYDRATE IN CLINICAL PRACTICE.
D000970:Antineoplastic Agents; D001792:Blood Platelets; D004906:Erythrocyte Count; D006689:Hodgkin Disease; D006801:Humans; D007938:Leukemia; D007945:Leukemia, Lymphoid; D007958:Leukocyte Count; D008198:Lymph Nodes; D008214:Lymphocytes; D008223:Lymphoma; D016403:Lymphoma, Large B-Cell, Diffuse; D008228:Lymphoma, Non-Hodgkin; D008353:Mannitol; D009369:Neoplasms; D013902:Radiography, Thoracic; D012509:Sarcoma
D000970:Antineoplastic Agents; D008353:Mannitol
ANTINEOPLASTIC AGENTS; BLOOD PLATELETS; ERYTHROCYTE COUNT; HODGKIN'S DISEASE; LEUKEMIA, LYMPHOCYTIC; LEUKOCYTE COUNT; LYMPH NODES; LYMPHOSARCOMA; MANNITOL; SARCOMA, RETICULUM CELL; THORACIC RADIOGRAPHY